Standard Family Office’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8
Closed -$1K 191
2021
Q2
$1K Hold
8
﹤0.01% 480
2021
Q1
$1K Buy
+8
New +$986 ﹤0.01% 512

Other funds holding DGX

Standard Family Office's DGX Position: Q3 2021 in Review

Standard Family Office sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 8 shares — an estimated $1K sold.

Standard Family Office first reported a position in DGX in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Standard Family Office reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Standard Family Office sold 8 Quest Diagnostics shares in Q3 2021, an estimated $1K.
  • Standard Family Office first reported a position in Quest Diagnostics in Q1 2021 and held it in 2 quarters.
  • Standard Family Office's Quest Diagnostics position peaked at $1K in Q2 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Standard Family Office's 13F filing for Q3 2021, filed 15 Nov 2021.